These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36006515)

  • 1. Assessment of postviral qualitative olfactory dysfunction using the short SSParoT in patients with and without parosmia.
    Sekine R; Menzel S; Hähner A; Mori E; Hummel T
    Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):469-472. PubMed ID: 36006515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of odor hedonic perception: the Sniffin' sticks parosmia test (SSParoT).
    Liu DT; Welge-Lüssen A; Besser G; Mueller CA; Renner B
    Sci Rep; 2020 Oct; 10(1):18019. PubMed ID: 33093474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthonasal and retronasal odor identification in patients with parosmia.
    Li S; Boscolo-Rizzo P; Uderzo F; Tirelli G; Whitcroft KL; Hummel T
    Eur Arch Otorhinolaryngol; 2023 Nov; 280(11):4933-4938. PubMed ID: 37338584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Patient Characteristics and Olfactory Sensitivity for Trigger Odorants in Parosmia and Phantosmia.
    Sekine R; Hernandez AK; Overbeck C; Hofer MK; Mori E; Hähner A; Hummel T
    Laryngoscope; 2024 Jul; 134(7):3277-3285. PubMed ID: 38578016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parosmia in patients with post-infectious olfactory dysfunction in the era of COVID-19-associated olfactory impairment.
    Gunder N; Hummel T
    HNO; 2024 Sep; 72(9):649-656. PubMed ID: 38935276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative smell/taste disorders as sequelae of acute COVID-19.
    Ercoli T; Masala C; Pinna I; Orofino G; Solla P; Rocchi L; Defazio G
    Neurol Sci; 2021 Dec; 42(12):4921-4926. PubMed ID: 34557966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified Olfactory Training Is an Effective Treatment Method for COVID-19 Induced Parosmia.
    Altundag A; Yilmaz E; Kesimli MC
    Laryngoscope; 2022 Jul; 132(7):1433-1438. PubMed ID: 35257391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing parosmia patients: a study on the evaluation method using a self-administered odor questionnaire for parosmia.
    Tei M; Mori E; Yonezawa N; Kishimoto Y; Tanaka H; Yanagi N; Tsurumoto Y; Nagai M; Sekine R; Otori N; Tsuzuki K
    Rhinology; 2024 Oct; 62(5):566-575. PubMed ID: 39066645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with parosmia respond faster to unpleasant odors than patients with hyposmia: Insights from olfactory event-related potentials.
    Li Z; Richter L; Krueger T; Eichwald H; Hähner A; Hummel T
    Int Forum Allergy Rhinol; 2024 Sep; 14(9):1446-1454. PubMed ID: 38584570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A parosmia severity index based on word-classification predicts olfactory abilities and impairment.
    Hörberg T; Sekine R; Overbeck C; Hummel T; Olofsson JK
    Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3695-3706. PubMed ID: 36906652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trigeminal function in patients with COVID-associated olfactory loss.
    Juratli JH; Garefis K; Konstantinidis I; Hummel T
    Eur Arch Otorhinolaryngol; 2024 May; 281(5):2403-2411. PubMed ID: 38127097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study on the prognostic significance of qualitative olfactory dysfunction.
    Reden J; Maroldt H; Fritz A; Zahnert T; Hummel T
    Eur Arch Otorhinolaryngol; 2007 Feb; 264(2):139-44. PubMed ID: 17006637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proof-of-concept: SCENTinel 1.1 rapidly discriminates COVID-19-related olfactory disorders.
    Hunter SR; Hannum ME; Pellegrino R; O'Leary MA; Rawson NE; Reed DR; Dalton PH; Parma V
    Chem Senses; 2023 Jan; 48():. PubMed ID: 36796784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parosmia is Associated with Relevant Olfactory Recovery After Olfactory Training.
    Liu DT; Sabha M; Damm M; Philpott C; Oleszkiewicz A; Hähner A; Hummel T
    Laryngoscope; 2021 Mar; 131(3):618-623. PubMed ID: 33210732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and assessment of qualitative olfactory dysfunction in different age groups.
    Nordin S; Murphy C; Davidson TM; Quiñonez C; Jalowayski AA; Ellison DW
    Laryngoscope; 1996 Jun; 106(6):739-44. PubMed ID: 8656960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subjective Perception of Recovery and Measured Olfactory Function in COVID-19 Patients.
    Cancellieri E; Hernandez AK; Degkwitz H; Kahre E; Blankenburg J; Horst TS; Czyborra P; Boscolo-Rizzo P; Hummel T
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and associated factors of qualitative olfactory dysfunction.
    Eo TS; Lee HY; Cho HJ; Yoon JH; Rha MS; Kim CH
    Rhinology; 2023 Oct; 61(5):432-440. PubMed ID: 37243721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent COVID-19 parosmia and olfactory loss post olfactory training: randomized clinical trial comparing central and peripheral-acting therapeutics.
    Cantone E; D'Ascanio L; De Luca P; Roccamatisi D; La La Mantia I; Brenner MJ; Di Stadio A
    Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3671-3678. PubMed ID: 38492007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the clinical usefulness of structured questions in parosmia assessment.
    Landis BN; Frasnelli J; Croy I; Hummel T
    Laryngoscope; 2010 Aug; 120(8):1707-13. PubMed ID: 20641087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent olfactory dysfunction in mild COVID-19 patients: A descriptive study of the characteristics and association with other symptoms.
    García-Meléndez DD; Morales-Casado MI; Quintana Castro P; Marsal Alonso C
    Med Clin (Barc); 2023 Apr; 160(8):347-351. PubMed ID: 36670030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.